Grant applications are open for Grant Period 3 (November 1st 2024-October 31st 2025)

Grant applications are open for Grant Period 3 (November 1st 2024-October 31st 2025)

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

STSM: Short Term Scientific Mission

Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be carried out and for a determined period of time.
First call: November 1st 2024 – April 30th 2025

VM: Virtual Mobility

Collaboration in a virtual setting among researchers or innovators within the IMMUNO-model COST Action, to exchange knowledge, learn new techniques, etc.

DC: Dissemination Conference

Funds an oral presentation by an Action Participant of the work of IMMUNO-model COST Action in a high-level conference fully organized by a third party, i.e. not organized nor co-organized by IMMUNO-model.

ITC: Inclusiveness Targeted Countries Conference

Funds an oral presentation of their own work within the scope of IMMUNO-model COST Action by an Action Participant affiliated to a legal entity located in an Inclusiveness Target Country / Near Neighbour Country in a high-level conference fully organized by a third party, i.e. not organized nor co-organized by IMMUNO-model.
New COST rules: oral presentation only, ALSO open to Near Neighbour Countries. No age limit!

YRI: Young Researchers and Innovators Conference

Funds a poster/oral presentation of their own work by a Young Researcher and Innovator (YRI = below 40 years old) in a high-level conference fully organized by a third party, i.e. not organized nor co-organized by IMMUNO-model.
New COST rules: YRI is a new type of grant specifically tailored for young researchers!

Am I eligible? https://www.cost.eu/am-i-eligible/
Annotated Rules FAQ: https://www.cost.eu/cost-actions/annotated-rules-qa/

For details please visit: https://www.immuno-model.eu/mobility-grants/

STSM contact: 
Grant Awarding Coordinator
Dr. Philippe Bertrand

Latest Updates

Medicinal chemistry of the PD-1/PD-L1 immune checkpoint: where organic chemistry, biochemistry, and immunology meet. Lukasz Skalniak,Associate Professor
ioAVATAR: Immune oncology Drug Discovery & Decision – Advanced ex Vivo Approach To Accelerate Response prediction for combined therapies in ovarian cancer”, is one of the 15 projects funded by...
Coming soon in March 2026, an IMMUNO-model event entitled: MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY The event will be held...
📅 When: February 9th, 2026📍 Where: To be confirmed in Barcelona (ES) Join us for a one-day international symposium exploring the latest advances in 3D modelling of immunotherapy, from patient-derived...
The 3rd IMMUNO-model TGRC Workshop, titled “Young Researchers and Innovators on Immunotherapies: The Future is Now”, took place at IPO Porto, Portugal, on 25 September 2025, in a hybrid format....
I was very pleased with the opportunity to present my team’s research work on the last day of the meeting. The findings I presented were freshly published in the Leukemia...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter